Endocrine Society Members Named to National Clinical Care Commission

Three Endocrine Society members have been appointed to the National Clinical Care Commission.

The Commission will evaluate and provide recommendations on federal programs related to complex metabolic or autoimmune diseases that result from insulin-related issues, such as diabetes.

The Society and its fellow Diabetes Advocacy Alliance members have supported the effort to establish the Commission, which will help the country undertake more proactive and innovative approaches to diabetes and its disease complications.

Society members serving on the Commission are:

  • William Herman, MD, MP.H, was elected to be the Commission’s chairman at its initial meeting Oct. 31. Herman, who was jointly nominated by the Society and the American Diabetes Association, is director of the Michigan Center for Diabetes Translational Research at the University of Michigan in Ann Arbor, Mich.
  • Ayotunde Dokun, MD, PhD, FACE, is chief of Endocrine Service, Division of Endocrinology, Diabetes and Metabolism at Regional One Health System in Memphis, Tenn. Dokun runs a translational research laboratory that studies the molecular mechanisms of vascular complications in diabetes.
  • M. Carol Greenlee, MD, FACP, FACE, is faculty co-chair of the Center for Medicare and Medicaid Innovation Transforming Clinical Practice Initiative in Grand Junction, Colo. A clinician with more than 30 years’ experience in private practice, she co-chaired the American College of Physicians (ACP) Medical Neighbor workgroup and was a lead author of the ACP position paper “The Patient-Centered Medical Home Neighbor.” She also serves on the Endocrine News Editorial Advisory Board.

The Commission consists of 23 voting members, including 11 heads of federal agencies. U.S. Department of Health and Human Services Sec. Alex Azar appointed 12 non-federal experts in prevention, care, and epidemiology of complex metabolic or autoimmune diseases that result from insulin-related issues.

The Office of Disease Prevention and Health Promotion (ODPHP) will provide management and support services for the Commission’s activities.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in